Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

Kristen Beyer, PharmD, Anthony Proli, PharmD, Junting Zheng, Sean Devlin, PhD, Valkal Bhatt, PharmD, Andrew Lin, PharmD, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD PhD, Miguel Perales, MD, Sergio Giralt, MD, Hugo Castro-Malaspina, MD, Roni Tamari, MD

Blood (2016) 128 (22): 3392.

https://doi.org/10.1182/blood.V128.22.3392.3392

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant with Ablative Conditioning Is Associated with Favorable Outcomes in Patients with Mixed Phenotype Acute Leukemia

Bartlomiej M Getta, MBBS, Junting Zheng, Martin S. Tallman, MD, Jae H. Park, MD, Eytan M. Stein, MD, Mikhail Roshal, MD PhD, Esperanza B. Papadopoulos, MD, Nancy A. Kernan, MD, Peter G. Steinherz, MD, Richard J. O'Reilly, MD, Miguel-Angel Perales, MD, Sergio A. Giralt, MD, Brian C. Shaffer, MD

Blood (2016) 128 (22): 3487.

https://doi.org/10.1182/blood.V128.22.3487.3487

Published: 2016

Journal Articles

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

Stephen J. Harnicar, PharmD, BCOP, BCPS, Doris M Ponce, MD, David Gregornik, PharmD, Sherry Mathew, PharmD, BCOP, Katherine L Evans, BA, Junting Zheng, MS, Sean Devlin, PhD, Melissa Pozotrigo, PharmD, BCOP, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Nelly G. Adel, PharmD, BCOP, BCPS, Juliet N Barker, MBBS, (Hons), FRACP

Blood (2013) 122 (21): 3297.

https://doi.org/10.1182/blood.V122.21.3297.3297

Published: 2013

Journal Articles

HHV-6 Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplant Recipients Transplanted without ATG

Amanda L. Olson, MD, Parastoo B. Dahi, MD, Junting Zheng, MS, Sean Devlin, PhD, Marissa N. Lubin, BA, Anne Marie Gonzales, BS, Sergio A. Giralt, MD, Doris M. Ponce, MD, Nancy A. Kernan, MD, Andromachi Scaradavou, MD, Genovefa Papanicolaou, MD, Juliet N. Barker, MBBS, (Hons), FRACP

Blood (2012) 120 (21): 459.

https://doi.org/10.1182/blood.V120.21.459.459

Published: 2012

Journal Articles

Disease-Free Survival After Cord Blood (CB) Transplantation Is Not Different to That After Related or Unrelated Donor Transplantation in Patients with Hematologic Malignancies.

Blood (2009) 114 (22): 2296.

https://doi.org/10.1182/blood.V114.22.2296.2296

Published: 2009

Journal Articles

Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation.

Jenna D. Goldberg, MD, Junting Zheng, MA, Juliet Barker, MBBS, Farid Boulad, MD, H.R. Castro-Malaspina, MD, Katharine C Hsu, MD, PhD, Ann Jakubowski, MD, PhD, Nancy Kernan, MD, Richard J O'Reilly,, MD, Esperanza Papadopoulos, MD, Susan Prockop, MD, Andromachi Scaradavou, MD, Marcel van den Brink, MD, PhD, James Young, MD, Glenn Heller, PhD, Miguel-Angel Perales, MD

Blood (2009) 114 (22): 2222.

https://doi.org/10.1182/blood.V114.22.2222.2222

Published: 2009

Journal Articles

Lack of HLA Class I Ligands for Autologous Inhibitory KIR Is Associated with Improved Survival Following Autologous Stem Cell Transplant for Children with Neuroblastoma.

Jeffrey M Venstrom, MD, Junting Zheng, MA, Reenat S Hasan, BS, Karen E Danis, MA, Irene Y Cheung, ScD, Bo Dupont, MD, DSc, Nai Kong Cheung, MD, PhD, Katharine C Hsu, MD, PhD

Blood (2008) 112 (11): 3322.

https://doi.org/10.1182/blood.V112.11.3322.3322

Published: 2008

Journal Articles

Pre-Treatment p27 and Bcl-6 Staining Levels Correlate with Response to Bortezomib in Non-Hodgkin Lymphoma: Results from a Tissue Microarray Analysis

John Gerecitano, Sivaraman Gounder, Julie Feldstein, Shahiba Ogilvie, Dorothy Lin, Junting Zheng, Zhigang Zhang, Alice McDonald, George Mulligan, Owen A. O’Connor

Blood (2007) 110 (11): 1294.

https://doi.org/10.1182/blood.V110.11.1294.1294

Published: 2007

NARROW

Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplant with Ablative Conditioning Is Associated with Favorable Outcomes in Patients with Mixed Phenotype Acute Leukemia

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

HHV-6 Viremia Is Frequent but the Incidence of Encephalitis Is Low in Double-Unit Cord Blood Transplant Recipients Transplanted without ATG

Disease-Free Survival After Cord Blood (CB) Transplantation Is Not Different to That After Related or Unrelated Donor Transplantation in Patients with Hematologic Malignancies.

Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation.

Lack of HLA Class I Ligands for Autologous Inhibitory KIR Is Associated with Improved Survival Following Autologous Stem Cell Transplant for Children with Neuroblastoma.

Pre-Treatment p27 and Bcl-6 Staining Levels Correlate with Response to Bortezomib in Non-Hodgkin Lymphoma: Results from a Tissue Microarray Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only